Survival of cancer of the pancreas. Bases for new strategies in diagnosis and therapy

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 5, 2000, Pages 321-325

  Boadas, J ^a   Balart, J ^a   Capella G ^b   Lluis F ^a,b   Farre Viladrich A ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Research Institute   (Spain)

Author keywords

Early diagnosis; Pancreatic carcinoma; Stage; Survival; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034183981     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Sánchez V, Borrás JM, Mingot M. Evolución de la mortalidad por cancer en Cataluna: 1975-1990. Med Clin (Barc) 1994;102:606-12.
2. Gonzalez Martínez J, Truan Alonso N, Turienzo E, Martínez D, Flórez L. Epidemiología del cáncer exocrino de páncreas en el Principado de Asturias 1973-1992. Rev Esp Enf Digest 1995;87:653-7.
3. La Vecchia C, Lucchini F, Negri E, Boyle P, Maisonneuve P, Levi F. Trends of cancer mortality in Europe, 1955-89: digestive sites. Eur J Cancer 1992;28:128-235.
4. Warshaw AL, Fernández del Castillo C. Pancreatic carcinoma. N Engl J Med 1992;326:455-65.
5. Farré A. Tumores del pánceas exocrino. En: Medicina interna, de Farreras-Rozman. Barcelona: Doyma; 1995:245-8.
6. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284-303.
7. a ed. Philadelphia: PÂ, JB Lippincott Co; 1993.
8. Urrutia R, DiMagno EP. Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer? Gastroenterology 1996;110:306-10.
9. Moossa AR, Levin B. The diagnosis of early pancreatic cancer: the University of Chicago experience. Cancer 1981;47:1688-97.
10. Porta M, Malats N, Alguacil J, Soler M, Rifà J. La búsqueda de factores de riesgo para el cáncer de páncreas: práctica, paciencia y paradigmas. Gastroenterol Hepatol 1997; 20:259-73.
11. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas 1992;7:66-86.
12. Warshaw AL, Gu Z-Y, Wittenberg J, Waltman AC. Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg 1990;125:230-3.
13. Hoe LV, Baert AL. Pancreatic carcinoma: applications for helical computed tomography. Endoscopy 1997;29:539-60.
14. Brugge WR. The role of endoscopic ultrasound in pancreatic disorders. Int J Pancreatol;1996;20:1-10.
15. Rosewicz S. Pancreatic carcinoma. Lancet 1997; 349:485-9.
16. Silverman DT, Schiffman M, Devesa S. Diagnostic certainly in exocrine pancreatic cancer. J Clin Epidemiol 1996; 49:602.
17. Porta M, Malats N, Piñol JL, Real FX, Rifà J. Relevance of misclassification of disease status in epidemiologic studies of exocrine pancreatic cancer. J Clin Epidemiol 1996;49: 602-3.
18. Shibata D, Capellà G, Perucho M. Mutational activation of the K-ras gene in human pancreatic carcinoma. Ballières Clin Gastroenterol 1991;4:151-69.
19. Caldas C, Kern S. K-ras mutation and pancreatic adenocarcinoma. Int J Pancreatol 1995;18:1-6.
20. Scarpa A, Capelli P, Villanueva A, Zamboni G, Lluís F, Accolla R, et al. Pancreatic cancer in Europe. Ki-ras gene mutation pattern shows geographical differences. Int J Cancer 1993;57:167-71.
21. Villanueva A, Reyes G, Cuatrecasas M, Martínez A, Erill N, Lerma E, et al Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses. Gastroenterology 1996;19:1587-94.
22. Mora J, Puig P, Boadas J, Urgell E, Montserrat E, Lerma E, et al. K-ras gene mutations in the diagnosis of fine-needle aspirates of pancreatic masses: a prospective study using two techniques of different sensitivity. Clin Chem 1998; 44:2243-8.
23. Rashleigh-Belcher HJC, Rusell RCG, Lees WR. Cutaneous seeding of pancreatic carcinoma by fine-needle aspiration biopsy. Br J Radiol 1986;59:182-3.
24. Connolly MM, Dawson PJ, Michelassi F, Moossa AR, Lowenstein F. Survival in 1,001 patients with carcinoma of the pancreas. Ann Surg 1987;206:366-73.
25. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H. Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 1994;81:102-7.
26. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman JAI. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-5.
27. Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989; 30:1132-5.
28. Åndren-Sandberg AA, Backman PL, Andersson R. Results of adjuvant therapy in resected pancreatic cancer. Int J Pancreatol 1997;21:31-8.
29. Link KH, Gansauge F, Pillascch J, Beger HG. Multimodal therapies in ductal pancreatic cancer. Int J Pancreatol 1997; 21:71-83.
30. Lemoine NR, Jain S, Hughes CM, Staddon SL, Maillet B, Hall P, Klöppel G. Ki-ras oncogen activation in preinvasive pancreatic cancer. Gastroenterology 1992;102:230-6.
31. Wakabayashi T, Sawabu N, Watanabe H, Morimoto H, Sugioka G, Takita Y. Detection of K-ras point mutation at codon 12 in pure pancreatic juice collected 3 years and 6 months before the clinical diagnosis of pancreatic cancer. Am J Gastroenterol 1996;91:1848-951.
32. Berthélemy P, Bouisson M, Escorrou J, Vaysse N, Rumeau JL, Pradayrol L. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Int Med 1995;123:188-91.
33. Boadas J, Mora J, Roca M, Cussó X, Puig P, Urgell E, et al. Analysis of the utility of K-ras gene mutations in pancreatic juice in the diagnosis of pancreatic cancer. Pancreas 1997;15:428.
34. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-73.
35. Tada M, Omata M, Kawai S, Saisho H, Ohio M, Saiki RK, Sninsky JJ. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993; 53:2472-4.
36. Iguchi H, Sugano K, Fukayama N, Ohkura H, Sadamoto K, Ohkoshi K, et al. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology 1996;110:221-6.
37. Lowenfelds AB, Maisonneuve P, Cavallini G, Ammann RW, Lankish PG, Andersen JR, et al and International Pancreatitis Study Group. Pancreatitis and risk of pancreatic cancer. N Engl J Med 1993;328:1433-7.
38. Kaiser MH, Ellenberg SS. Pancreatic cancer adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
39. Foo ML, Gunderson LI, Nagorney DM, McLlarath DC, Van Heerden JA, Robinow JS, et al. Paterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5-fluorouracil. Int J Radiat Oncol Biol Phys 1993;26:483-9.
40. Yeo CJ, Cameron JL, Lillemore KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreatoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-33.
41. Rich TA, Evans DB. Preoperative combined modality therapy for pancreatic cancer. World J Surg 1997;19:264-9.
42. Staley CA, Lee EJ, Clearly KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation thrapy for adenocarcinoma of the pancreatic head. Am J Surg 1996; 171:118-25.
43. Bramhall SR, Neoptolemos JP. Adjuvant chemotherapy in pancreatic cancer. Int J Pancreatol 1997;21:59-63.
44. Weese JL, Nussbaum ML, Paul AR, Engstrom PF, Solin LJ, Kowalyshyn MJ, Hoffman JP. Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy. Int J Pancreatol 1990;7:177-85.
45. Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA, et al. A phase II trial of gemcitabine in patients with 5-FU refractory pancreas cancer. Ann Oncol 1996;7:347-53.